526 related articles for article (PubMed ID: 27671687)
1. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
Liu Y; Bi T; Wang Z; Wu G; Qian L; Gao Q; Shen G
Apoptosis; 2016 Dec; 21(12):1398-1407. PubMed ID: 27671687
[TBL] [Abstract][Full Text] [Related]
2. Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.
Liu Y; Bi T; Dai W; Wang G; Qian L; Gao Q; Shen G
Tumour Biol; 2016 Jun; 37(6):7589-97. PubMed ID: 26687645
[TBL] [Abstract][Full Text] [Related]
3. Oxymatrine induces cell cycle arrest and apoptosis and suppresses the invasion of human glioblastoma cells through the EGFR/PI3K/Akt/mTOR signaling pathway and STAT3.
Dai Z; Wang L; Wang X; Zhao B; Zhao W; Bhardwaj SS; Ye J; Yin Z; Zhang J; Zhao S
Oncol Rep; 2018 Aug; 40(2):867-876. PubMed ID: 29989652
[TBL] [Abstract][Full Text] [Related]
4. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
5. GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway.
Yu T; An Q; Cao XL; Yang H; Cui J; Li ZJ; Xiao G
Life Sci; 2020 Nov; 260():118294. PubMed ID: 32818544
[TBL] [Abstract][Full Text] [Related]
6. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
Liu Y; Xiao E; Yuan L; Li G
DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
[TBL] [Abstract][Full Text] [Related]
7. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway.
ShuoWang ; Song Z; Gong X; Ou C; Zhang W; Wang J; Yao C; Qin S; Yan B; Li Q; Wei K; Hou X; Zhou X; Miao J
J Ethnopharmacol; 2021 May; 271():113879. PubMed ID: 33524509
[TBL] [Abstract][Full Text] [Related]
8. Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.
You S; Li W; Guan Y
Mol Med Rep; 2018 Mar; 17(3):4203-4212. PubMed ID: 29344654
[TBL] [Abstract][Full Text] [Related]
9. Metformin synergistically enhances antitumor activity of cisplatin in gallbladder cancer via the PI3K/AKT/ERK pathway.
Bi T; Zhu A; Yang X; Qiao H; Tang J; Liu Y; Lv R
Cytotechnology; 2018 Feb; 70(1):439-448. PubMed ID: 29110119
[TBL] [Abstract][Full Text] [Related]
10. Oxymatrine protects against DSS-induced colitis via inhibiting the PI3K/AKT signaling pathway.
Chen Q; Duan X; Fan H; Xu M; Tang Q; Zhang L; Shou Z; Liu X; Zuo D; Yang J; Deng S; Dong Y; Wu H; Liu Y; Nan Z
Int Immunopharmacol; 2017 Dec; 53():149-157. PubMed ID: 29107215
[TBL] [Abstract][Full Text] [Related]
11. Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.
Kumar S; Agnihotri N
Biomed Pharmacother; 2019 Jan; 109():1462-1477. PubMed ID: 30551398
[TBL] [Abstract][Full Text] [Related]
12. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
[TBL] [Abstract][Full Text] [Related]
13. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.
Zhang R; Lian Y; Xie K; Cai Y; Pan Y; Zhu Y
Bioengineered; 2021 Dec; 12(2):9162-9173. PubMed ID: 34696683
[TBL] [Abstract][Full Text] [Related]
14. Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K/Akt/mTOR Signaling Pathway.
Long J; Pi X
Biomed Res Int; 2020; 2020():5149417. PubMed ID: 32733943
[TBL] [Abstract][Full Text] [Related]
15. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
17. Enhanced in vitro tumoricidal effects of 5-Fluorouracil, thymoquinone, and active vitamin D
Idris S; Refaat B; Almaimani RA; Ahmed HG; Ahmad J; Alhadrami M; El-Readi MZ; Elzubier ME; Alaufi HAA; Al-Amin B; Alghamdi AA; Bahwerth F; Minshawi F; Kabrah SM; Aslam A
Life Sci; 2022 May; 296():120442. PubMed ID: 35245520
[TBL] [Abstract][Full Text] [Related]
18. Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways.
Zhang L; Huo X; Liao Y; Yang F; Gao L; Cao L
Sci Rep; 2017 May; 7(1):1669. PubMed ID: 28490807
[TBL] [Abstract][Full Text] [Related]
19. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
Jiang JH; Pi J; Jin H; Cai JY
J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
[TBL] [Abstract][Full Text] [Related]
20. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]